Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene

Helicobacter

Volumn 12, Issue 5, 2007, Pages 505-509

  Garrido, Leonardo ^a   Toledo, Hector ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

23S rRNA gene; Antibiotic resistance; Clarithromycin resistance

Indexed keywords

BACTERIAL RNA; CLARITHROMYCIN; RIBOSOME RNA; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA GENE; URBAN AREA;

ANTI-BACTERIAL AGENTS; CHILE; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GENES, RRNA; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 34548189029     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00506.x     Document Type: Article

References (22)

1. Rene WM, Hulst VD, Keller JJ, Rauws AJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996 1 : 6 19.
2. Hoffman JS, Cave DR. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 2001 17 : 30 4.
3. Vallejos C, Garrido L, Cáceres D, Madrid AM, Defilippi C, Defilippi CC, Toledo H. Prevalencia de la resistencia a metronidazol, claritromicina y tetraciclina en Helicobacter pylori: estudio de base hospitalaria. Rev Méd Chile 2007 135 : 287 93.
4. Goldman RC, Zakula D, Flamm R, Beyer I, Capobianco I. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 1994 38 : 1496 500.
5. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996 40 : 477 80.
6. Vandoorn LJ, Debets-Ossenkopp YJ, Marais A, Sanna R, Mégraud F, Kusters JG, Quint WGV. Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 1999 43 : 1779 82.
7. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of the two copies of 23S rRNA genes from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997 41 : 2621 8.
8. Occhialini A, Urdaci M, Doucet-Populaire F, Bebear CM, Lamouliatte H, Mégraud F. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997 41 : 2724 8.
9. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J, Idler K, Zulawinski L, Tanaka SK. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996 1 : 227 8.
10. Hultén K, Gibreel A, Skold O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997 41 : 2550 3.
11. Kim KS, Kang JO, Eun CS, Han DS, Choi TY. Mutation in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance. J Korean Med Sci 2002 17 : 599 603.
12. González C, García A, Daroch F, Kawaguchi F, Solar H, Rivera N, Vega E. Susceptibilidad in vitro de cepas de Helicobacter pylori: aislamiento de cepas resistentes a claritromicina. Rev Méd Chile 2001 129 : 643 6.
13. Cerda O, Rivas A, Toledo H. Helicobacter pylori strain ATCC700392 encodes a methyl-accepting chemotaxis receptor protein (MCP) for arginine and sodium bicarbonate. FEMS Microbiol Letters 2003 224 : 175 81.
14. Mégraud F, Bonnet F, Garnier M, Lamouliatte H. Characterization of Campylobacter pyloridis by culture, enzymatic profile, and protein content. J Clin Microbiol 1985 22 : 1007 10.
15. National Committee for Clinical Laboratory Standards. Approved standard M100-S10. MIC testing supplemental tables. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
16. Bruce MG, Bruden DL, McMahon BJ, et al. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native Persons, 1999-2003. Helicobacter 2006 11 : 581 8.
17. Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Aliment Pharmacol Ther 2001 15 : 707 13.
18. Heep M, Kist M, Strobel S, Beck D, Lehn N. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 2000 19 : 538 41.
19. Kim JJ, Kim JG, Kwon DH. Mixed infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003 8 : 202 6.
20. Wang GE, Jiang Q, Taylor DE. Genotypic characterization of clarithromycin-resistant and susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. J Clin Microbiol 1998 36 : 2730 1.
21. Vester B, Douhwaite S. Macrolide resistance by base substitutions in the 23S rRNA. Antimicrob Agents Chemother 2001 45 : 1 12.
22. Wang G, Taylor DE. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide- streptogramin B antibiotics. Antimicrob Agents Chemother 1998 42 : 1952 8.